"Latest COVID-19 Vaccine Shows 54% Effectiveness Against Symptomatic Infection"

TL;DR Summary
The latest COVID-19 vaccines are 54% effective at preventing symptomatic infection in adults, according to a study by the CDC. The study looked at 9,000 people who got tested for COVID-19 at pharmacies and found that the effectiveness is similar to what's been reported in other countries. Further studies will assess the effectiveness at preventing severe symptoms. The CDC recommends the new shots for everyone 6 months and older, but uptake in the U.S. has been slow, with only about 22% of adults and 11% of children having received the shots.
Topics:health#cdc#covid-19-vaccines#effectiveness#health-covid-19#new-variants#symptomatic-infection
- Newest COVID shots are 54% effective in preventing symptoms, CDC finds ABC News
- Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to CDC
- New estimates show latest COVID vaccine cuts risk of symptomatic infection University of Minnesota Twin Cities
- The New COVID-19 Shot Is Surprisingly Effective Against the Latest Variant TIME
- Updated Covid vaccine has 54% effectiveness, new study suggests STAT
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
1 min
vs 2 min read
Condensed
64%
254 → 91 words
Want the full story? Read the original article
Read on ABC News